Mandarin Capital Management SA
Mandarin buys stake in ceramic manufacturer La Fabbrica
GP backed the company’s MBI through its Mandarin Capital Partners II vehicle
Mandarin hires two in Italy and Germany
GP boosts its Milan team with a new partner and new head of its German office
Mandarin Capital partner Solibieda leaves for BASF Venture Capital
Solibieda has left the Milanese GP after three years as head of private equity in its German office
Clessidra, Mandarin et al. sell Euticals to Amri for $358m
Deal sees the GP syndicate acquire a 19.75% stake in US-listed buyer Amri
Mandarin invests €12m in Marval
Sino-Italian GP has committed an additional €6m investment to the business
Progressio joins existing investors in ICF
Progressio secures a controlling stake in the business together with Mandarin Capital
Mandarin closes second fund on €200m
Figure falls far below €500m target vehicle launched with in March 2013
Ardian acquires Italmatch from Mandarin
Italmatch senior management retains 12% stake
Hutton Collins injects €50m into Dedalus
Hutton Collins has made a €50m investment in Dedalus, an Italian healthcare IT systems provider, along with a further €15m from co-investors.
Family offices pose competitive threat to German GPs
Family offices
LPs demand Asian presence for portfolio growth
Eastern promises
Mandarin Capital announces first close
Sino-Italian investor Mandarin Capital Partners has announced a first close of its second fund on €110.5m.
Mandarin Capital sells IMA
Sino-Italian investor Mandarin Capital Partners has sold its stake in Bologna-based pharmaceutical machinery business IMA Group.
Mandarin Capital sells Gasket
Mandarin Capital Partners (MCP) has sold its shareholding in Italian valves components producer Gasket International to Hutchinson, a French thermoplastics firm.
Q&A: Alberto Forchielli, Mandarin Capital Partners
Founding partner Alberto Forchielli speaks to Amy King about expectations for the firm's current fundraise, why Germany is the only option left for Chinese industrial investment and Chinese GPs’ lack of international presence.